ANIP: Lalwani Nikhil sold $388K of stock
By AlphaYouPublished Form 4
Lalwani Nikhil
Reporting filer
Lalwani Nikhil reported selling 5,400 shares of Ani Pharmaceuticals Inc for about $388K ($71.89 a share on average). Form 4 filed Oct 16, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 16, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Lalwani Nikhil | 2026-10-15 | S | Sale | 5400 | 71.89 | 333,689 | 1 day | Filed terms
|
Common Stock
- Owner
- Lalwani Nikhil
- Date
- 2026-10-15
- Code
- S
- Action
- Sale
- Quantity
- 5400
- Price
- 71.89
- Following holdings
- 333,689
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 5400
- transaction Price Per Share: 71.89
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 333689
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Lalwani Nikhil: PRESIDENT & CEO, Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2026.
- F2: The shares were sold in multiple trades at prices ranging from $71.08 to $72.56. The price reported above reflects the weighted average sales price.
Original sources
Prepared automatically from public filing data. Report a correction.